Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals
Juan Berenguer(Hospital General Universitario Gregorio Marañón), Juan González‐García, Ángela Gil‐Martin(Madrid Health Service), Marisa Montes(Hospital La Paz Institute for Health Research), Ignacio de los Santos, Maria Clara Costa Calvo(Universidad del Zulia), Inmaculada Jarrín, Jesús Troya(Hospital Universitario Infanta Leonor), Juan Emilio Losa, Teresa Aldámiz‐Echevarría(Hospital General Universitario Gregorio Marañón), María Teresa de Guzmán(Hospital Universitario Infanta Cristina), Lourdes Domínguez(Hospital Universitario 12 De Octubre), María Jesús Téllez(Hospital Clínico San Carlos), Regino Serrano(Hospital Universitario del Henares)
Cited by 58
Related Papers
Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
|International Journal of Reproductive Medicine|2014|451
Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2006|137
Efficacy of senna versus lactulose in terminal cancer patients treated with opioids
|Journal of Pain and Symptom Management|1998|95
All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice
|Hepatology|2018|79
Prevalence and Associated Factors of Insulin Resistance in Adults from Maracaibo City, Venezuela
|Advances in Preventive Medicine|2016|72